Shelter Pharma will participate in the iPHEX 2026 exhibition at Bharat Mandapam. This strategic move aims to enhance global visibility and explore new export opportunities.
Tata Technologies received Frost & Sullivan’s 2026 Asia-Pacific Company of the Year award for autonomous vehicle engineering. The recognition highlights its global leadership in ADAS solutions.
FDC Limited scheduled a board meeting for May 27, 2026, to approve audited financial results. This provides advance notice for upcoming performance disclosures.
Borosil Renewables paid ₹0.02 Crore in penalties to stock exchanges for delayed financial results. The company also received an NSE advisory letter regarding lock-in non-compliance.
Anjani Portland Cement scheduled a board meeting for May 27, 2026. Directors will consider audited standalone and consolidated financial results for fiscal year 2026.
Shri Vasuprada Plantations scheduled a board meeting on May 22, 2026. Directors will consider audited standalone and consolidated financial results for the 2026 fiscal year.
Coforge Limited allotted 3,52,818 equity shares worth ₹8.60 Crore under its ESOP Scheme. The company's paid-up capital increased to approximately ₹86 Crore following this issuance.
Netlink Solutions (India) Limited scheduled an EGM for June 9, 2026, to confirm director appointments. The board also approved a promoter reclassification request from Mr. Minesh Modi.
Permanent Magnets Limited filed its annual Secretarial Compliance Report for FY 2025-26. The report confirms overall regulatory adherence, though one promoter shareholding remains in physical form.
Dollar Industries Ltd scheduled a board meeting on May 23, 2026. Directors will consider FY26 audited financial results and recommend potential equity dividends.
MTNL reported a ₹9,339.68 Crore default on principal and interest payments across seven banks. Significant financial distress signals heightened credit risk for investors.
Latteys Industries scheduled a board meeting on May 22, 2026, to approve audited financial results. Trading window closure for designated persons is currently in effect.
Muthoot Capital Services Debt & Borrowing: ₹0.95 Cr
Muthoot Capital Services Limited confirmed interest payment of ₹0.95 Crore for debentures bearing ISIN INE296G07317. The payment ensures compliance with debt servicing obligations.
Imagicaaworld Entertainment Capacity Expansion: ₹100 Cr Investment
Imagicaaworld is investing ₹100 Crore in Gujarat's largest water park. The deal includes operations management, expanding the company's regional footprint and leisure market presence.
Pil Italica Lifestyle submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms regulatory adherence with no material non-compliances noted.
Man Infraconstruction Capacity Expansion: ₹1,000 Cr Investment
Man Infraconstruction acquired an ultra-luxury sea-view residential project in Bandra with ₹1,000 Crore GDV. This acquisition strengthens its premium Mumbai portfolio and future launch pipeline.
The board recommended a final dividend of ₹0.1 per equity share for 2026. Payment is scheduled by August 31, 2026, pending shareholder approval at the general meeting.
BCL Industries scheduled a board meeting for May 25, 2026, to approve audited financial results and dividend. The trading window remains closed until results are declared.
Sandu Pharmaceuticals filed its Annual Secretarial Compliance Report for the year ended March 2026. The auditor confirmed general regulatory compliance with minor previous reporting delays noted.
Tejas Cargo clarified that recent share price movements are purely market-driven. The company confirmed no pending material information or undisclosed price-sensitive events exist.
Lead Reclaim and Rubber Products reported ₹39.82 Cr revenue and ₹4.09 Cr PAT for FY26. Management is pivoting towards higher-margin verticals like TPO, RCB, and EPDM to drive future profitability.
Transpek Industry scheduled a board meeting on May 26, 2026, to approve audited financial results. Directors will also consider a dividend recommendation for fiscal year 2025-26.
FDC Limited received U.S.FDA ANDA approval for Cefixime Oral Suspension USP in two strengths. This regulatory milestone enables the company to market these products in the US.
Saven Technologies confirmed that Regulation 24A secretarial compliance is not applicable. The company remains below regulatory thresholds for paid-up capital and net worth.
Pritika Auto Industries scheduled a board meeting for May 23, 2026, to approve audited financial results for FY26. Trading windows remain closed for designated persons.
GEE Limited reported strong FY26 performance with Revenue at ₹3,691.4 Mn (up 10.6% YoY) and PAT at ₹130 Mn (up 240.7% YoY). Management is pivoting toward a high-margin, specialized product strategy.
OCCL Limited scheduled a board meeting for May 21, 2026, to approve audited FY26 financial results. Directors will also consider recommending an equity dividend.